Moneycontrol PRO
Upcoming Event:Join us for New HorAIzon from Oct 6-7, 2pm and be a part of exciting conversations on tech & innovation

Buy Divis Laboratories, sell L&T Finance; see 10-15% upside in Amara Raja: Sudarshan Sukhani

According to Sudarshan Sukhani of s2analytics.com, one may buy Divis Laboratories.

December 12, 2017 / 12:09 PM IST

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "It is a consolidating market today, slightly on the weaker side. So there are buying and selling opportunities both. I have Divis Laboratories as a buy. It has been an underperformer and that seems to be getting over it now and pharmaceutical in any case is coming out of a long bear market. Today Divis Laboratories is suggesting more momentum on the upside."

"Financials were weak in the morning, we had financials as a short sell, that theme continues for the day. L&T Finance is a short sell as we speak but try to avoid short sells as a carry forward trade, it is only for the day intraday."

"NIIT Technologies from the IT pack is a buy. Midcap IT is doing well and that theme continues today. So it is a mixed bag. Take short sells in the financials and PSU banks and exit by the end of the day."

"Hindustan Unilever (HUL) and Infosys are bluechips in their own way. You will be surprised to see where HUL will be after three to five years and Infosys is probably getting the worst behind it. So please do not sell, this is not the right time to sell, it is the right time to buy on a dip, hold."

"Amara Raja has gone through a very deep correction and that is good news because the correction is behind the stock performance. For the next one year I would expect at least a 10-15 percent gain in this stock, probably more because it is a midcap, it can see a bounce anytime. So at this point, one should keep it as a hold, stay for a year," he added.
CNBC-TV18
first published: Dec 12, 2017 11:49 am
Sections
ISO 27001 - BSI Assurance Mark